ARMI | BioFabUSA will be speaking at the 13th Annual Wisconsin Stem Cell Symposium.
ARMI Speakers will include:
Richard McFarland, Chief Regulatory Officer
This Symposium is coordinated by the Stem Cell & Regenerative Medicine Center, at the University of Wisconsin-Madison and the BTC Institute. It brings together leading researchers advancing human pluripotent stem cell products to clinical applications for a range of degenerative diseases. Progress in clinical trials will be highlighted as well as major barriers for developing these revolutionary new therapies.
Human pluripotent stem cell therapies for diabetes, ocular disease, spinal cord injury, Parkinson’s disease, and heart failure
Biomanufacturing of clinical grade cellular products
Overcoming immunological barriers for human pluripotent stem cell-based therapies
Defining safe and effective human pluripotent stem cell clinical products